Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F8N1J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,634
Award facts
- Contract value 100% obligated
- $12,634.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $12,634.42. This is a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, issued on December 2, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vehicle provides comprehensive global pharmaceutical support, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. REPATHA is a PCSK9 inhibitor used for cholesterol management and cardiovascular disease prevention in eligible patient populations within military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F8N1J?
SPE2DR26F8N1J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F8N1J worth?
The government has obligated $12,634 on SPE2DR26F8N1J.
Is contract SPE2DR26F8N1J an order under another contract?
Yes. SPE2DR26F8N1J is a delivery order under SPE2DR25D3022, an indefinite delivery contract.
Was contract SPE2DR26F8N1J competed?
The extent of competition for SPE2DR26F8N1J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award